Table 2. Diseases associated with Clostridium perfringens.
Type of C. perfringens* | Major toxins | Most significant diseases** |
---|---|---|
A | CPA*** | Human and animal myonecrosis (gas gangrene); |
CPA, CPE*** | Human food poisoning and non-foodborne gastrointestinal disease; canine gastrointestinal disease | |
CPA, NetB*** | Necrotic enteritis of poultry | |
B | CPA, CPB, ETX | Human biodefense concerns (ETX); necro-hemorrhagic enteritis of sheep (lamb dysentery) |
C | CPA, CPB*** | Human necrotic enteritis (enteritis necroticans, pigbel); necrotic enteritis of neonatal individuals of several animal species (horse, cattle, sheep, pigs) |
D | CPA, ETX*** | Human biodefense concerns (ETX); enterotoxemia of sheep and goats |
E | CPE, ITX | No known association with human disease; suspected, but not confirmed association with gastrointestinal disease of cattle, sheep and rabbits. |
All types of C. perfringens may also produce several other toxins, including, but not limited to, CPB2, PFO, and TpeL. **Only diseases that have been confirmed to be associated with each type of C. perfringens, and that are significant in terms of prevalence, are included in this table. ***Critical toxin for virulence. PFO also contributes to virulence during myonecrosis (see text). Some type C, D, and E strains also produce CPE.